Ocular Therapeutix Inc.

(OCUL) Trade

By |

Profile

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, PTX-TP, and OTX-IVT. The ReSure product is commercially available.

Contact Information

Website: www.ocutx.com
Email: dnotman@ocutx.com
Main Phone: +1 781 357-4000
Address: 15 Crosby Drive
Address 2: Suite 105
State: MA
City / Town: Bedford
Country: USA
Postal Code: 01730

Issuer Information

Exchange: NSD
CEO: Antony C. Mattessich
Employees: 119
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.82 $ -0.25 (-4.12%)
Last Price 5.82 Change $ -0.25 Change % -4.12 Tick N/A
Bid 5.51 Bid Size 1,000.00 Ask 6.34 Ask Size 3,000.00
Open 6.08 High 6.13 Low 5.68 Prev Close 6.07
Last Trade Volume 693,664 52 Wk Hi 8.28 52 Wk Low 4.17
Market Cap 239.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,095,372.00 EPS (TTM) -1.59 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 6
Number of Buys 0 6
Number of Sells 0 0
Net Activity 0 258893
Last 10 Buys Shares
Antony C. Mattessich 1,000
Donald Notman 1,000
Daniel M. Bollag 1,000
Amarpreet Sawhney 1,000
Amarpreet Sawhney 1,000
Amarpreet Sawhney 1,000
Amarpreet Sawhney 1,000
Amarpreet Sawhney 1,000
Amarpreet Sawhney 1,000
Eric Ankerud 1,000
Last 10 Sell Shares
James Fortune 1,000
Charles Warden 1,000
Charles Warden 1,000
Charles Warden 1,000
Charles Warden 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 22 22 22 22
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 13 13 13 13
Standard Deviation 6.22 6.22 6.22 6.22
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 5 6
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.29 1.29 1.33 1.29